Animal Studies Show Ortec's Fibrin Microbeads Recover Up To Four Times The Number Of Stem Cells As Conventional Methods

Source: Ortec International, Inc.
Posted: May 17, 2006

Summary:

Ortec International, Inc., a company focused on development and commercialization of products applicable to regenerative medicine and stem cell therapy, announced results of experiments in a rat model demonstrating that Ortec's Fibrin Microbeads (FMB) technology increases by nearly fourfold the yield of Mesenchymal Stem Cells recovered from bone marrow. The results also showed that the cells isolated by FMB could be expanded in culture for more than four months and could be differentiated into bone, fat and cartilage cells.

Commentary: It seems that if this technique could be used to grow human stem cells, it may be possible to accelerate the development of stem cell therapies to treat diseases, injuries and conditions.